Northwest Cancer Specialists, PC,265 N. Broadway

Portland, Oregon 97227

0 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer Third Line, PD-L1 Positive, Triple Negative Breast Cancer, Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) — Completed